The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanamaru, Y.
Right arrow Articles by Blank, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanamaru, Y.
Right arrow Articles by Blank, U.
The Journal of Immunology, 2006, 176: 5607-5615.
Copyright © 2006 by The American Association of Immunologists

Mast Cell-Mediated Remodeling and Fibrinolytic Activity Protect against Fatal Glomerulonephritis1

Yutaka Kanamaru2,*, Lisa Scandiuzzi2,*, Marie Essig*, Cristiana Brochetta*, Claudine Guérin-Marchand*, Yasuhiko Tomino{dagger}, Renato C. Monteiro*, Michel Peuchmaur{ddagger} and Ulrich Blank3,*

* Institut National de la Santé et de la Recherche Médicale Unité 699, Bichat Medical School, Paris, France; {dagger} Division of Nephrology, Department of Internal Medicine, Jutendo University, School of Medicine, Tokyo, Japan; and {ddagger} Service de Pathologie, Hôpital Robert Debré, Assistance Publique-Hôpitaux de Paris, Establissement Associé 3102, and Université Paris 7, Paris, France

Mast cells are detrimental in several inflammatory diseases; however, their physiological roles are also increasingly recognized. Recent data suggest that mast cells may also be involved in renal diseases. We therefore used congenitally mast cell-deficient W/Wv mice and normal +/+ littermates to assess their role in anti-glomerular basement membrane-induced glomerulonephritis. Following administration of anti-glomerular basement membrane Abs, W/Wv mice exhibited increased mortality as compared with +/+ mice owing to rapid deterioration of renal function. Reconstitution of the mast cell population in W/Wv mice restored protection. This was independent of activating Fc{gamma}R, as protection was also obtained using mast cells deficient in FcR{gamma}. Comparative histological analysis of kidneys showed that deterioration of renal function was caused by the presence of thick layers of subendothelial glomerular deposits in W/Wv mice, while +/+ mice or mast cell-reconstituted W/Wv mice showed significantly less. Deposits appeared during the early phase of disease and persisted thereafter, and were accompanied by enhanced macrophage recruitment. Immunohistochemical analysis revealed increased amounts of fibrin and type I collagen in W/Wv mice, which were also unable to maintain high tissue plasminogen activator and urinary-type plasminogen activator activity in urine in the heterologous phase of disease. Our results indicate that mast cells by their ability to mediate remodeling and repair functions are protective in immune complex-mediated glomerulonephritis.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
P. Boor, K. Sebekova, T. Ostendorf, and J. Floege
Treatment targets in renal fibrosis
Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3391 - 3407.
[Full Text] [PDF]


Home page
J. Immunol.Home page
K. Hochegger, A. R. Rosenkranz, F. Siebenhaar, and M. Maurer
Comment on "Mast Cell-Mediated Remodeling and Fibrinolytic Activity Protect against Fatal Glomerulonephritis"
J. Immunol., August 1, 2006; 177(3): 1377 - 1377.
[Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Kanamaru, L. Scandiuzzi, M. Essig, R. C. Monteiro, and U. Blank
Response to Comment on "Mast Cell-Mediated Remodeling and Fibrinolytic Activity Protect against Fatal Glomerulonephritis"
J. Immunol., August 1, 2006; 177(3): 1377 - 1378.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.